Related Experiment Videos

Release of plasminogen activator from normal and neoplastic endometrium

L Svanberg, B Astedt

Experientia

|June 15, 1979

Abstract:

In the medium of endometrial carcinoma cultures, anti-urokinase-reacting plasminogen activator was released in contrast to cultures of normal or hyperplastic endometrium.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Chocolate swelling during storage caused by fat or moisture migration.

Journal of food science·2012

A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.

Maturitas·2009

A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004

Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.

Diabetologia·1999

High tissue content of urokinase plasminogen activator (u-PA) is associated with high stromal expression of u-PA mRNA in poorly differentiated serous ovarian carcinoma.

International journal of cancer·1998

Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy.

Seminars in thrombosis and hemostasis·1998

See all related articles